Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research I1 Apr 2015MP37-16 A NKX3.1 BINDING SITE POLYMORPHISM IN THE L-PLASTIN PROMOTER LEADS TO DIFFERENTIAL GENE EXPRESSION IN HUMAN PROSTATE CANCER Jian Huang, Changhao Chen, Tianxin Lin, Wang He, and Xu Chen Jian HuangJian Huang More articles by this author , Changhao ChenChanghao Chen More articles by this author , Tianxin LinTianxin Lin More articles by this author , Wang HeWang He More articles by this author , and Xu ChenXu Chen More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.1279AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The L-plastin gene is a potential cancer biomarker and a therapeutic target that induces invasion and metastasis of prostate cancer. L-plastin gene is mutated in almost all prostate cancer cell lines. Thus, it is reasonable to elucidate that occurring polymorphic genetic variants in the L-plastin promoter might cause an individual's susceptibility to prostate cancer. METHODS A single nucleotide polymorphism (SNP)-1687 is found in the L-plastin promoter by genotype sequencing. The TRANSFAC software was applied to predict the multiple cis-elements and the luciferase assay was used to identify the L-plastin regulatory region. We conducted the ChIP-qPCR, Electrophoretic mobility shift assay (EMSA), and supershift assays to evaluate the activity of NKX3.1 transcription factor on the L-plastin promoter, and the impact of the SNP-1687 on NKX3.1 binding affinity. The functions of NKX3.1 on cell proliferation, colony formation were evaluated by knockdown strategy in vitro. RESULTS We performed ChIP, EMSA and supershift assays to reveal that transcription suppressor NKX3.1 bound to L-plastin promoter and was affected the affinity of promoter region by the SNP-1687. The SNP-1687 located in L-plastin promoter led to an increase of the affinity with NKX3.1, resulting in lower levels of L-plastin RNA and protein and the reduction of tumor cell growth and metastasis. Furthermore, between May 2000 and June 2013, we collected and sequenced 640 individuals' samples (372 prostate cancer cases and 268 healthy controls) from multicenter institutions. The results showed that mutated genotype T allele incidence of SNP -1687 were higher in the healthy individuals (16.4%; 65.0%, respectively) than in the prostate cancer patients (10.8%; 60.8%, respectively), which demonstrated that SNP-1687 homozygous TT occurred more frequently in the healthy individuals than in the prostate cancer patients compared with wide type CC (P=0.036). There was a tendency that SNP-1687T allele occurred more frequently in the subgroup of prostate cancer patients with low recurrence risk and well and moderately differentiated grade. CONCLUSIONS Our findings suggested that the SNP-1687 located in the NKX3.1 binding sites within L-plastin promoter may affect L-plastin expression, which in turn may affect prostate tumorigenesis and progression. In addition, this SNP may have the potential to become a prognostic factor for prostate cancer. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e443-e444 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jian Huang More articles by this author Changhao Chen More articles by this author Tianxin Lin More articles by this author Wang He More articles by this author Xu Chen More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Identification of Transcription Factor AP-4 as the Regulator that Upregulates the Expression of L-plastin in Hormone-Independent Prostate Cancer

Identification of Transcription Factor SP-1 Upregulating the Expression of L-plastin in Hormone-Independent Prostate Cancer

[Identification of Response Element Gene Sequence for Non-Steroid Hormone Transcription Factors for the Activation and Up-Regulation of L-plastin Expression in Prostate Cancer].

AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L -plastin

Transcriptional Regulation of Pp2a-A Alpha is Mediated by Multiple Factors Including Ap-2 Alpha, Creb, Ets-1, and Sp-1

MP99-07 AP4 PROMOTES PROLIFERATION AND METASTASIS OF CASTRATION-RESISTANT PROSTATE CANCER THROUGH BINDING AND UP-REGULATION OF L-PLASTIN

Estrogen Receptor Alpha Up-Regulates Transcription Activity of L-plastin Promoter in Prostate Cancer Cell Line LNCaP

The Regulation of Steroid Hormone Receptor AR and ER in the Expression of L-plastin in Prostate Cancer

The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating LAPTM4B Expression

The Novel KLF4/PLAC8 Signaling Pathway Regulates Lung Cancer Growth.

TR4 Nuclear Receptor Enhances the Cisplatin Chemo-Sensitivity Via Altering the ATF3 Expression to Better Suppress HCC Cell Growth

Single Nucleotide Polymorphism -1751C/T of L- Plastin Promoter Leads to Binding Activity of NKX3.1 Transcription Factor in Prostate Cancer

AP4 Positively Regulates LAPTM4B to Promote Hepatocellular Carcinoma Growth and Metastasis, While Reducing Chemotherapy Sensitivity

Evaluating the Prognostic Value and Functional Roles of Transcription Factor AP4 in Colorectal Cancer.

Supplementary Table S3 from The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating <i>LAPTM4B</i> Expression

Supplementary Figure S1 from the Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating <i>laptm4b</i> Expression

Supplementary Figure S3 from the Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating <i>laptm4b</i> Expression

Overexpression of Transcription Factor Activating Enhancer Binding Protein 4 (TFAP4) Predicts Poor Prognosis for Colorectal Cancer Patients.

TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway.

MP37-16 A NKX3.1 BINDING SITE POLYMORPHISM IN THE L-PLASTIN PROMOTER LEADS TO DIFFERENTIAL GENE EXPRESSION IN HUMAN PROSTATE CANCER

The Prostate Cancer-Up-regulated Long Noncoding RNA PlncRNA-1 Modulates Apoptosis and Proliferation Through Reciprocal Regulation of Androgen Receptor.